052260 is the Korean stock ticker for HYUNDAI BIOLAND Co., Ltd., a KOSDAQ-listed Korean public company in Chemicals & Materials.
This ticker has no publisher-linked research report in the current collection.
052260 is the Korean stock ticker for HYUNDAI BIOLAND Co., Ltd., a KOSDAQ-listed Korean public company in Chemicals & Materials. Business activity: Natural bioactive ingredient research, development, manufacturing and sales. Business activity: Health supplement brand distribution. Product/service: Cosmetic ingredients including Hyaluronic Acid. Product/service: Functional food and dietary supplement ingredients. Product/service: Medicinal herb pharmaceutical ingredients. Product/service: Soy isoflavone, rhodiola and ginkgo extracts. Customer exposure: Cosmetics, functional food and biomedical brand companies. Customer exposure: OEM and ODM companies. Customer exposure: Global corporate customers.
052260 is a Korean stock ticker that trades on KOSDAQ as a common share tracked by Korean Tickers with data.go.kr daily public data, DART filings, and USD reference values.
HYUNDAI BIOLAND Co., Ltd. is classified by Korean Tickers under Chemicals & Materials, with official issuer and industry context shown on the company profile.
| Item | TTM 26 Q2 LTM / latest balance sheet | 26 Q2 Standalone quarter | 26 Q1 Standalone quarter | 2025 Annual | 2024 Annual | Change vs 2025 |
|---|---|---|---|---|---|---|
| Revenue | $101.96M ₩140.7B | $29.18M ₩40.3B | $27.70M ₩38.2B | $94.57M ₩130.5B | $86.61M ₩119.5B | +7.8% |
| Gross Profit | $41.22M ₩56.9B | $13.08M ₩18.0B | $11.17M ₩15.4B | $38.80M ₩53.5B | $38.29M ₩52.8B | +6.3% |
| Operating Income | $10.49M ₩14.5B | $5.10M ₩7.0B | $3.76M ₩5.2B | $9.22M ₩12.7B | $11.86M ₩16.4B | +13.8% |
| Net Income | $9.67M ₩13.3B | $4.32M ₩6.0B | $3.78M ₩5.2B | $183K ₩252.6M | $4.13M ₩5.7B | +5183.7% |
| Cash & Equivalents | $6.44M ₩8.9B | $6.44M ₩8.9B | $5.99M ₩8.3B | $12.87M ₩17.8B | $15.22M ₩21.0B | -49.9% |
| Current Assets | $67.73M ₩93.5B | $67.73M ₩93.5B | $63.36M ₩87.4B | $66.74M ₩92.1B | $77.64M ₩107.1B | +1.5% |
| Receivables | $15.82M ₩21.8B | $15.82M ₩21.8B | $15.90M ₩21.9B | $11.07M ₩15.3B | $9.65M ₩13.3B | +42.9% |
| Inventory | $32.18M ₩44.4B | $32.18M ₩44.4B | $34.21M ₩47.2B | $38.19M ₩52.7B | $41.59M ₩57.4B | -15.8% |
| Total Assets | $120.50M ₩166.3B | $120.50M ₩166.3B | $117.02M ₩161.5B | $120.92M ₩166.9B | $141.11M ₩194.7B | -0.3% |
| Current Liabilities | $13.39M ₩18.5B | $13.39M ₩18.5B | $14.10M ₩19.5B | $20.45M ₩28.2B | $40.40M ₩55.8B | -34.5% |
| Total Liabilities | $15.02M ₩20.7B | $15.02M ₩20.7B | $15.83M ₩21.8B | $22.26M ₩30.7B | $41.10M ₩56.7B | -32.5% |
| Total Equity | $105.48M ₩145.6B | $105.48M ₩145.6B | $101.19M ₩139.6B | $98.66M ₩136.1B | $100.01M ₩138.0B | +6.9% |